Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Viking Therapeutics, Inc. - Common Stock
(NQ:
VKTX
)
25.36
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Therapeutics, Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
34
35
Next >
Viking Therapeutics Posts Wider Q2 Loss
↗
July 23, 2025
Via
The Motley Fool
Viking Therapeutics Stock Slides After Company Misses Q2 Earnings Estimates
↗
July 23, 2025
Viking Therapeutics shares fall in Wednesday's after-hours session after the company reported financial results for the second quarter.
Via
Benzinga
Viking (VKTX) Q2 2025 Earnings Call Transcript
↗
July 23, 2025
Via
The Motley Fool
Topics
Earnings
Intellectual Property
12 Health Care Stocks Moving In Wednesday's After-Market Session
↗
July 23, 2025
Via
Benzinga
Viking Therapeutics Inc (NASDAQ:VKTX) Posts Wider Q2 2025 Loss, Shares Drop in After-Hours Trading
↗
July 23, 2025
Viking Therapeutics reports wider Q2 2025 loss, missing EPS estimates, causing a 5.7% after-hours dip. Focus remains on clinical pipeline progress amid revenue challenges.
Via
Chartmill
Earnings Scheduled For July 23, 2025
↗
July 23, 2025
Via
Benzinga
A Look Ahead: Viking Therapeutics's Earnings Forecast
↗
July 22, 2025
Via
Benzinga
Better Growth Buy: Eli Lilly vs. Viking Therapeutics
↗
July 22, 2025
Via
The Motley Fool
3 Monster Stocks in the Making to Buy Right Now
↗
July 21, 2025
Via
The Motley Fool
These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?
↗
July 20, 2025
Via
The Motley Fool
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.
↗
July 19, 2025
Yet another biopharma name has been run through a familiar trading cycle that often ends on a bullish note.
Via
The Motley Fool
Topics
Intellectual Property
The Best Stocks to Invest $1,000 In Right Now
↗
July 15, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
Better Growth Buy: Eli Lilly vs. Viking Therapeutics
↗
July 07, 2025
Via
The Motley Fool
Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity
↗
July 04, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
2 Beaten-Down Stocks With Massive Upside Potential
↗
July 03, 2025
Via
The Motley Fool
10 Incredible Growth Stocks Poised for Long-Term Gains
↗
July 02, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Got $200? 2 Biotech Stocks to Buy and Hold Forever
↗
July 01, 2025
Via
The Motley Fool
Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
↗
June 30, 2025
The company announced a new drug that uses the same mechanism as Eli Lilly's retatrutide.
Via
Investor's Business Daily
3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking
June 29, 2025
Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value
Via
MarketBeat
Topics
Artificial Intelligence
Economy
Why This Weight Loss Drug Company's Stock Surged Today
↗
June 26, 2025
Via
The Motley Fool
3 Growth Stocks I'm Loading Up On
↗
June 26, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Government
Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity
↗
June 25, 2025
The company just initiated two Phase 3 studies of its weekly under-the-skin shot to stoke weight loss.
Via
Investor's Business Daily
What's Going On With Viking Therapeutics Stock On Wednesday?
↗
June 25, 2025
Viking Therapeutics begins Phase 3 trials for VK2735, testing weekly injections in over 5,000 adults with obesity or type 2 diabetes over 78 weeks.
Via
Benzinga
My 5 Favorite Dirt Cheap Stocks to Buy Right Now
↗
June 24, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
World Trade
Amgen Expands Development Plans For Highly Anticipated Obesity Drug
↗
June 23, 2025
Amgen is expanding its plans for weight-loss drug, MariTide, with a trio of upcoming Phase 3 studies.
Via
Investor's Business Daily
2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts
↗
June 21, 2025
Via
The Motley Fool
Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
↗
June 18, 2025
Via
The Motley Fool
Are These 2 High-Flying Growth Stocks Still Worth Buying After Recent Pullbacks?
↗
June 16, 2025
Via
The Motley Fool
Topics
Government
10 Health Care Stocks Whale Activity In Today's Session
↗
June 10, 2025
Via
Benzinga
1 Stock Down 34% This Year to Buy and Hold
↗
June 08, 2025
Via
The Motley Fool
< Previous
1
2
...
7
8
9
10
11
12
13
14
15
...
34
35
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
